APA

Mariotti F., Govoni M., Lucci G., Santoro D. & Nandeuil M. A. (20190307). Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers. : International journal of chronic obstructive pulmonary disease.

Chicago

Mariotti Fabrizia, Govoni Mirco, Lucci Germano, Santoro Debora and Nandeuil Marie Anna. 20190307. Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers. : International journal of chronic obstructive pulmonary disease.

Harvard

Mariotti F., Govoni M., Lucci G., Santoro D. and Nandeuil M. A. (20190307). Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers. : International journal of chronic obstructive pulmonary disease.

MLA

Mariotti Fabrizia, Govoni Mirco, Lucci Germano, Santoro Debora and Nandeuil Marie Anna. Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers. : International journal of chronic obstructive pulmonary disease. 20190307.